Valuation: Amedica Corporation

Market Cap 6.78M 5.93M 5.47M 5.03M 9.53M 653M 9.69M 65.29M 25.62M 319M 25.47M 24.91M 1.1B P/E 2026 *
-0.73x
P/E 2027 * -1.1x
Enterprise Value 6.78M 5.93M 5.47M 5.03M 9.53M 653M 9.69M 65.29M 25.62M 319M 25.47M 24.91M 1.1B EV / Sales 2026 *
2.94x
EV / Sales 2027 * 1.29x
Free-Float
65.08%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 30/11/2007
President - 15/03/2026
Director of Finance/CFO 41 03/09/2025
Director TitleAgeSince
Director/Board Member 63 30/11/2007
Director/Board Member 63 02/04/2025
Director/Board Member 72 04/11/2012
Change 5-day change 1-year change 3-year change Capi.($)
-7.92%-7.29% - - 6.78M
+1.73%-3.18%-18.98%+4.63% 121B
-1.17%+0.71%+3.83%-3.68% 13.07B
+2.88%+2.54%+59.62%+98.31% 9.21B
+9.11%+8.59%-45.41%-70.81% 4.2B
+3.08%+11.31%+15.91%+54.14% 2.91B
+3.86%-2.49%-15.39%-27.03% 1.73B
+1.54%+4.12%-5.20%-19.99% 1.67B
+3.81%+8.29%-17.18%-60.78% 1.47B
Average +1.88%+3.70%-2.85%-3.15% 19.45B
Weighted average by Cap. +1.82%-1.70%-12.27%+7.13%

Financials

2026 *2027 *
Net sales 2.3M 2.01M 1.86M 1.71M 3.24M 222M 3.29M 22.18M 8.7M 108M 8.65M 8.46M 373M 5.27M 4.61M 4.25M 3.91M 7.4M 507M 7.53M 50.72M 19.9M 248M 19.78M 19.35M 854M
Net income -12.38M -10.82M -9.98M -9.18M -17.39M -1.19B -17.69M -119M -46.77M -582M -46.49M -45.47M -2.01B -11.38M -9.95M -9.18M -8.43M -15.98M -1.09B -16.25M -110M -42.98M -535M -42.72M -41.79M -1.84B
Net Debt - -
Logo Amedica Corporation
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-